Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Letter to the Editor

Definition of Psychosomatic Medicine and the Applicability of DSM-IV-TR to Outpatients Visiting a Japanese Psychosomatic Clinic

Nakao M.a · Takeuchi T.a · Fricchione G.b

Author affiliations

aDepartment of Psychosomatic Medicine, Teikyo University Hospital, Tokyo, Japan; bDivision of International Psychiatry and The Benson Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA

Related Articles for ""

Psychother Psychosom 2014;83:120-121

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

Received: April 06, 2013
Accepted: July 01, 2013
Published online: January 22, 2014
Issue release date: March 2014

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 1

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS


First-Page Preview
Abstract of Letter to the Editor

References

  1. The Committee of Education and Training of the Japanese Society of Psychosomatic Medicine: An updated treatment guideline of psychosomatic medicine (in Japanese). Jpn J Psychosom Med 1991;31:537-576.
  2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text revision. Washington, American Psychiatric Press, 2000.
  3. Nakao M, Takeuchi T, Yano E: Prescription of benzodiazepine in comparison with SSRI and SNRI for outpatients attending a Japanese university hospital. Int J Clin Pharmacol Ther 2007;45:30-35.
  4. Nakao M, Nomura S, Yamanaka G, Kumano H, Kuboki T: Assessment of patients by DSM-III-R and DSM-IV in a Japanese psychosomatic clinic. Psychother Psychosom 1998;67:43-49.
  5. SAS Institute Inc: SAS Institute SAS/STAT User's Guide, Release 8.01 Edition. Cary, SAS Institute Inc, 1999.
  6. Gerrits MM, van Oppen P, van Marwijk HW, van der Horst H, Penninx BW: The impact of chronic somatic diseases on the course of depressive and anxiety disorders. Psychother Psychosom 2013;82:64-66.
  7. Rundell JR, Amundsen K, Rummans TL, Tennen G: Toward defining the scope of psychosomatic medicine practice: psychosomatic medicine in an outpatient, tertiary-care practice setting. Psychosomatics 2008;49:487-493.
  8. Voigt K, Wollburg E, Weinmann N, Herzog A, Meyer B, Langs G, Löwe B: Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder: comparison with DSM-IV somatoform disorders and additional criteria for consideration. J Psychosom Res 2012;73:345-350.
  9. Fava GA, Belaise C, Sonino N: Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatry. Curr Psychiatry Rep 2010;12:215-221.
  10. Sharma MP, Manjula M: Behavioural and psychological management of somatic symptom disorders: an overview. Int Rev Psychiatry 2013;25:116-124.

Article / Publication Details

Received: April 06, 2013
Accepted: July 01, 2013
Published online: January 22, 2014
Issue release date: March 2014

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 1

ISSN: 0033-3190 (Print)
eISSN: 1423-0348 (Online)

For additional information: https://www.karger.com/PPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.